explore -WSS

explore

author：Wikipedia 2025-10-01 02:16:05 - browse：4

Ed Silverman on the Breakthrough Summit stage in 2023. — STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

Below, you can find a lightly edited transcript of the conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Wikipedia

WSS

Phenylephrine and the overlooked value of the placebo effect

Chemotherapy drug shortage eases slightly but still widespread

3 questions for the future of Biden's cancer moonshot

What to expect at HLTH 2023, the health care industry conference

Analysis of telehealth claims data suggest service duplication

The future of health care in the House

hotspot

explore

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Senate panel eyes new effort on drug shortages

Heart attack and stroke risk calculators need revising

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Trump demands the U.S. pay no more for drugs than other countries … again

Senate panel eyes new effort on drug shortages

Virginia high school admissions case could be legal follow

Histogen: Failed biotech offers rare public look inside

Medicare details structure of new drug price negotiation program

FDA authorizes Novavax’s updated Covid

explore

AI can decode, harness the power of the humane immune system

What to expect at HLTH 2023, the health care industry conference

What to expect at HLTH 2023, the health care industry conference

Colorectal cancer study finds potential in overlooked immune cell

Was Amgen transparent enough on FDA's concern on cancer drug?

Colorectal cancer study finds potential in overlooked immune cell

Wikipedia

entertainment

leisure time

explore